First Time Loading...

Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262

Watchlist Manager
Jiangsu Nhwa Pharmaceutical Co Ltd Logo
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Watchlist
Price: 23.45 CNY -0.38%
Updated: Jun 11, 2024

Jiangsu Nhwa Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Nhwa Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Revenue
¥5B
CAGR 3-Years
14%
CAGR 5-Years
5%
CAGR 10-Years
8%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥10.6B
CAGR 3-Years
16%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥23.3B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.4B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
¥561.9m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue?
Revenue
5B CNY

Based on the financial report for Dec 31, 2023, Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue amounts to 5B CNY.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Jiangsu Nhwa Pharmaceutical Co Ltd have been 14% over the past three years , 5% over the past five years , and 8% over the past ten years .